Fig 1.
Conceptual diagram of the effect of salt reduction on the CVD prevention.
AMI, acute myocardial infarction; BMI, body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; SBP, systolic blood pressure.
Table 1.
Mean SBP levels, salt intake level, and relative risks of CVD associated with SBP changes within CVD Policy Model categories.
Table 2.
Main assumptions for the effect of salt intervention and CVD treatment costs, the CVD Policy Model-China.
Fig 2.
Annual benefits of CVD prevention projected for salt intake interventions by region in China.
Bars represent the main simulation point estimate. I bars indicate 95% uncertainty intervals of the gained benefit among the overall population from 1 000 probabilistic simulations. CVD, cardiovascular disease; Int$, international dollars; QALY, quality-adjusted life years.
Table 3.
Simulated SBP reductions and annual cardiovascular disease outcomes (coronary heart disease and stroke combined) after achieving dietary salt reduction goals in China, from 2010 to 2019, according to the CVD Policy Model-China.
Table 4.
Simulated SBP reduction and annual cardiovascular disease outcomes (coronary heart disease and stroke combined) after implementing dietary salt intervention strategies in China, 2010 to 2019, according to the CVD Policy Model-China.
Fig 3.
Simulated annual number of CVD events prevented by salt restriction strategies by hypertension status.